LncRNA MNX1-AS1 Promotes Progression of Intrahepatic Cholangiocarcinoma Through the MNX1/Hippo Axis

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2020 Oct 23

PMID 33093444

Citations 15

Authors

Fengwei Li

Qinjunjie Chen

Hui Xue

Lei Zhang

Kui Wang

Feng Shen

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) have extremely complex roles in the progression of intrahepatic cholangiocarcinoma (ICC) and remain to be elucidated. By cytological and animal model experiments, this study demonstrated that the expression of lncRNA MNX1-AS1 was remarkably elevated in ICC cell lines and tissues, and was highly and positively correlated with motor neuron and pancreas homeobox protein 1 (MNX1) expression. MNX1-AS1 significantly facilitated the proliferation, migration, invasion, and angiogenesis in ICC cells in vitro, and remarkably promoted tumor growth and metastasis in vivo. Further study revealed that MNX1-AS1 promoted the expression of MNX1 via recruiting transcription factors c-Myc and myc-associated zinc finger protein (MAZ). Furthermore, MNX1 upregulated the expression of Ajuba protein via binding to its promoter region, and subsequently, Ajuba protein suppressed the Hippo signaling pathway. Taken together, our results uncovered that MNX1-AS1 can facilitate ICC progression via MNX1-AS1/c-Myc and MAZ/MNX1/Ajuba/Hippo pathway, suggesting that MNX1-AS1 may be able to serve as a potential target for ICC treatment.

Citing Articles

MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy.

Ni G, Sun Y, Jia H, Xiahou Z, Li Y, Zhao F Transl Oncol. 2025; 52:102280.

PMID: 39805182 PMC: 11780959. DOI: 10.1016/j.tranon.2025.102280.

Long Non-Coding RNA SNHG3 Promotes the Progression of Cholangiocarcinoma by Regulating the miR-151a-3p/STAT5a Axis.

Wei X, Cun D, Yang D, Yi Q, Tian D Turk J Gastroenterol. 2024; 35(12):933-944.

PMID: 39641310 PMC: 11639604. DOI: 10.5152/tjg.2024.24140.

Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance.

Fayyaz F, Shokati Eshkiki Z, Karamzadeh A, Moradi Z, Kaviani F, Namazi A Heliyon. 2024; 10(1):e23826.

PMID: 38226210 PMC: 10788524. DOI: 10.1016/j.heliyon.2023.e23826.

LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression.

Liu H, Gao Z, Li F, Guo X, Li C, Zhang H Cell Death Differ. 2023; 31(2):188-202.

PMID: 38114778 PMC: 10850524. DOI: 10.1038/s41418-023-01247-5.

NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.

Zhang H, Zhai X, Liu Y, Xia Z, Xia T, Du G Research (Wash D C). 2023; 6:0184.

PMID: 37398932 PMC: 10313139. DOI: 10.34133/research.0184.

References

Shen Z, Li Y, Fang Y, Lin M, Feng X, Li Z . SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development. Mol Oncol. 2019; 14(2):387-406. PMC: 6998659. DOI: 10.1002/1878-0261.12626. View

Wang Y, Wang J, Zhang L, Karatas O, Shao L, Zhang Y . RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression. Cancer Res. 2017; 77(16):4247-4257. PMC: 5559317. DOI: 10.1158/0008-5472.CAN-17-0669. View

Wang J, Xing H, Nikzad A, Liu B, Zhang Y, Li S . Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis. J Pharmacol Exp Ther. 2019; 372(3):237-247. DOI: 10.1124/jpet.119.262949. View

Tsuchiya H, Amisaki M, Takenaga A, Honjo S, Fujiwara Y, Shiota G . HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma. Int J Mol Sci. 2019; 20(22). PMC: 6888623. DOI: 10.3390/ijms20225714. View

Cheng Y, Pan Y, Pan Y, Wang O . MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer. Cancer Manag Res. 2019; 11:803-812. PMC: 6340505. DOI: 10.2147/CMAR.S188007. View

Wang Y, Yan X, Tian S . Downregulating long non-coding RNA CCAT5 inhibits tumor growth, invasion and metastasis in colorectal cancer through suppressing STAT3. Eur Rev Med Pharmacol Sci. 2019; 23(18):7899-7904. DOI: 10.26355/eurrev_201909_19001. View

Wang Y, He L, Du Y, Zhu P, Huang G, Luo J . The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015; 16(4):413-25. DOI: 10.1016/j.stem.2015.03.003. View

Melo C, Leveille N, Rooijers K, Wijchers P, Geeven G, Tal A . A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response. Oncogene. 2016; 35(33):4399-406. DOI: 10.1038/onc.2015.502. View

Huang Z, Zhou J, Wang K, Chen H, Qin S, Liu J . PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma. Hepatology. 2019; 71(5):1643-1659. DOI: 10.1002/hep.30930. View

10.

Tian T, Wang M, Zhu Y, Zhu W, Yang T, Li H . Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer. Mol Ther Nucleic Acids. 2018; 13:399-406. PMC: 6205149. DOI: 10.1016/j.omtn.2018.09.014. View

11.

Shuai Y, Ma Z, Liu W, Yu T, Yan C, Jiang H . TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Mol Cancer. 2020; 19(1):6. PMC: 6953272. DOI: 10.1186/s12943-019-1104-1. View

12.

Li O, Yi W, Yang P, Guo C, Peng C . Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122. Exp Ther Med. 2019; 18(1):25-32. PMC: 6566031. DOI: 10.3892/etm.2019.7564. View

13.

Bridgewater J, Galle P, Khan S, Llovet J, Park J, Patel T . Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014; 60(6):1268-89. DOI: 10.1016/j.jhep.2014.01.021. View

14.

Guan L, Li T, Ai N, Wang W, He B, Bai Y . MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019; 38(1):417. PMC: 6796342. DOI: 10.1186/s13046-019-1417-3. View

15.

Ji D, Wang Y, Sun B, Yang J, Luo X . Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis. Biochem Biophys Res Commun. 2019; 513(3):669-674. DOI: 10.1016/j.bbrc.2019.04.012. View

16.

Yang X, Pan Q, Lu Y, Jiang X, Zhang S, Wu J . MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer. Cell Biol Int. 2019; 43(4):402-408. DOI: 10.1002/cbin.11096. View

17.

Chen M, Wu R, Li G, Liu C, Tan L, Xiao K . Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2. J Exp Clin Cancer Res. 2018; 37(1):154. PMC: 6048799. DOI: 10.1186/s13046-018-0829-9. View

18.

Zhou Y, Huan L, Wu Y, Bao C, Chen B, Wang L . LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. Cancer Lett. 2019; 469:399-409. DOI: 10.1016/j.canlet.2019.11.007. View

19.

Shahabi S, Kumaran V, Castillo J, Cong Z, Nandagopal G, Mullen D . Is an Epigenetically Regulated Tumor Suppressor Essential for Activation of the DNA Damage Response. Cancer Res. 2019; 79(12):3050-3062. PMC: 6571057. DOI: 10.1158/0008-5472.CAN-18-2034. View

20.

Yu Z, Lun S, He R, Tian H, Huang H, Wang Q . Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression. Cancer Lett. 2017; 402:142-152. DOI: 10.1016/j.canlet.2017.05.020. View